PTKFF
PT Kalbe Farma Tbk.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Sell
-24/100
Last price
0.05
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.05
Day high
0.04
Day low
0.04
Volume
10.00K
Market cap
$2.37B
P/E (TTM)
—
52W range
0.04 – 0.08
Trailing performance
Returnvs SPY
1W
0.00%
-2.0%
1M
0.00%
-1.5%
3M
+30.02%
+26.6%
6M
-11.19%
-26.2%
YTD
-27.02%
-41.0%
1Y
-16.29%
-32.1%
3Y
-54.36%
-136.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PTKFF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
29.35B
Total on file
Fundamentals
Market cap$2.37B
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA$5.04T
Net income—
EPS (TTM)$0.00
Free cash flow$1.98T
Total cash—
Total debt—
Book value / share$507.02
Shares outstanding45.25B
Float17.99B
Short % of float—
Dividend yield2.13%
Beta (5Y)-0.05
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio2.92
Price / sales—
Price / book0.00
EV / revenue—
EV / EBITDA—
Gross margin37.37%
Operating margin0.00%
Profit margin9.57%
Return on equity14.77%
Return on assets9.22%
Debt / equity3.21
Current ratio3.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $35.32T | $32.63T | $30.45T | $28.93T | +8.3% |
| Operating revenue | $35.32T | $32.63T | $30.45T | $28.93T | +8.3% |
| Cost of revenue | $21.27T | $19.67T | $18.63T | $17.23T | +8.1% |
| Gross profit | $14.06T | $12.96T | $11.82T | $11.70T | +8.5% |
| Research & development | $499.71B | $471.60B | $329.62B | $293.32B | +6.0% |
| Selling, general & admin | $5.45T | $4.79T | $4.45T | $4.23T | +13.7% |
| Total operating expense | $9.51T | $8.89T | $8.20T | $7.48T | +7.0% |
| Operating income | $4.55T | $4.07T | $3.63T | $4.22T | +11.7% |
| Net interest income | $128.40B | $109.87B | -$6.89B | $26.77B | +16.9% |
| Pre-tax income | $4.78T | $4.22T | $3.61T | $4.46T | +13.3% |
| Tax provision | $1.03T | $972.30B | $827.83B | $1.01T | +6.4% |
| Net income | $3.66T | $3.24T | $2.77T | $3.38T | +13.1% |
| Net income to common | $3.66T | $3.24T | $2.77T | $3.38T | +13.1% |
| Basic EPS | 80.51 | 70.16 | 59.81 | 72.71 | +14.8% |
| Diluted EPS | 80.51 | 70.16 | 59.81 | 72.71 | +14.8% |
| EBIT | $4.81T | $4.28T | $3.69T | $4.50T | +12.6% |
| EBITDA | $5.18T | $4.60T | $4.02T | $4.83T | +12.6% |
| Basic shares | 45.52B | 46.19B | 46.26B | 46.52B | -1.4% |
| Diluted shares | 45.52B | 46.19B | 46.26B | 46.52B | -1.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.33T | $4.72T | $3.23T | $3.95T | -8.3% |
| Cash & short-term investments | $4.49T | $4.87T | $3.40T | $4.10T | -7.8% |
| Accounts receivable | $5.65T | $4.86T | $4.65T | $4.61T | +16.2% |
| Inventory | $6.99T | $6.50T | $6.79T | $7.03T | +7.4% |
| Total current assets | $18.51T | $17.19T | $15.92T | $16.71T | +7.7% |
| Property, plant & equipment | $8.74T | $8.78T | $8.54T | $8.34T | -0.5% |
| Goodwill & intangibles | $2.32T | $2.33T | $1.81T | $1.55T | -0.6% |
| Total assets | $30.70T | $29.43T | $27.06T | $27.24T | +4.3% |
| Total current liabilities | $5.34T | $4.19T | $3.24T | $4.43T | +27.5% |
| Current debt | $112.35B | $322.11B | $278.29B | $829.30B | -65.1% |
| Long-term debt | $143.02B | $194.99B | $298.34B | $287.03B | -26.7% |
| Total debt | $297.28B | $559.22B | $618.54B | $1.17T | -46.8% |
| Total liabilities | $5.97T | $4.84T | $3.94T | $5.14T | +23.4% |
| Retained earnings | $24.94T | $22.94T | $21.16T | $20.19T | +8.7% |
| Shareholder equity | $23.31T | $22.79T | $21.42T | $20.39T | +2.3% |
| Working capital | $13.17T | $13.00T | $12.67T | $12.28T | +1.3% |
| Net tangible assets | $21.00T | $20.46T | $19.61T | $18.84T | +2.6% |
| Shares issued | 46.81B | 46.88B | 46.88B | 46.88B | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$809.87B | -$1.25T | -$1.18T | -$870.10B | +35.2% |
| Investing cash flow | -$799.89B | -$1.25T | -$1.14T | -$1.37T | +35.9% |
| Share buybacks | -$842.09B | -$460.49B | $0 | -$1.00T | -82.9% |
| Dividends paid | -$1.64T | -$1.43T | -$1.76T | -$1.63T | -14.1% |
| Financing cash flow | -$2.87T | -$2.09T | -$2.44T | -$2.41T | -37.2% |
| Free cash flow | $2.46T | $3.53T | $1.73T | $401.79B | -30.4% |
| End cash position | $4.33T | $4.72T | $3.23T | $3.95T | -8.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $9.80T | $9.68T | $9.34T | — | $8.23T | $8.79T | +1.3% |
| Operating revenue | $9.80T | $9.68T | $9.34T | — | $8.23T | $8.79T | +1.3% |
| Cost of revenue | $6.19T | $5.97T | $5.84T | $5.38T | $4.88T | — | +3.7% |
| Gross profit | $3.61T | $3.71T | $3.50T | $3.53T | $3.35T | — | -2.6% |
| Research & development | $122.60B | $113.14B | $154.31B | — | $136.97B | $106.84B | +8.4% |
| Selling, general & admin | $1.52T | $1.38T | $1.16T | $1.69T | $1.30T | — | +9.8% |
| Total operating expense | $2.46T | $2.39T | $2.22T | $2.69T | $2.30T | — | +2.8% |
| Operating income | $1.15T | $1.32T | $1.28T | — | $1.05T | $1.38T | -12.4% |
| Net interest income | $33.09B | $23.83B | $30.49B | — | $32.66B | $37.42B | +38.9% |
| Pre-tax income | $1.18T | $1.35T | $1.30T | — | $1.18T | $1.43T | -12.5% |
| Tax provision | $262.72B | $299.20B | $251.74B | — | $265.89B | $318.81B | -12.2% |
| Net income | $890.54B | $1.03T | $1.03T | — | $898.17B | $1.08T | -13.5% |
| Net income to common | $890.54B | $1.03T | $1.03T | — | $898.17B | $1.08T | -13.5% |
| Basic EPS | — | 22.74 | — | — | — | 23.57 | — |
| Diluted EPS | — | 22.74 | — | — | — | 23.57 | — |
| EBIT | $1.19T | $1.36T | $1.31T | — | $1.19T | $1.44T | -12.3% |
| EBITDA | $1.26T | $1.44T | $1.39T | — | $1.30T | $1.52T | -12.5% |
| Basic shares | — | 45.25B | — | — | — | 45.69B | — |
| Diluted shares | — | 45.25B | — | — | — | 45.69B | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.83T | $4.39T | $4.33T | $3.80T | $4.54T | +10.0% |
| Cash & short-term investments | $4.99T | $4.55T | $4.49T | $3.95T | $4.69T | +9.6% |
| Accounts receivable | $6.58T | $6.34T | $5.65T | $5.64T | $6.01T | +3.9% |
| Inventory | $7.92T | $7.41T | $6.99T | $6.86T | $6.56T | +6.9% |
| Total current assets | $20.98T | $19.91T | $18.51T | $17.57T | $18.40T | +5.4% |
| Property, plant & equipment | $8.76T | $8.71T | $8.74T | $8.61T | $8.74T | +0.5% |
| Goodwill & intangibles | $2.30T | $2.31T | $2.32T | $2.32T | $2.35T | -0.2% |
| Total assets | $33.08T | $31.99T | $30.70T | $29.51T | $30.58T | +3.4% |
| Total current liabilities | $6.65T | $5.60T | $5.34T | $4.65T | $4.53T | +18.8% |
| Current debt | $628.05B | $110.35B | $112.35B | $558.05B | $293.66B | +469.1% |
| Long-term debt | $155.16B | $146.40B | $143.02B | $178.17B | $189.73B | +6.0% |
| Total debt | $825.35B | $304.26B | $297.28B | $779.98B | $531.72B | +171.3% |
| Total liabilities | $7.31T | $6.25T | $5.97T | $5.32T | $5.22T | +17.0% |
| Retained earnings | $25.95T | $25.97T | $24.94T | $23.25T | $24.02T | -0.1% |
| Shareholder equity | $24.33T | $24.30T | $23.31T | $22.40T | $23.52T | +0.1% |
| Working capital | $14.33T | $14.31T | $13.17T | $12.92T | $13.86T | +0.1% |
| Net tangible assets | $22.03T | $21.99T | $21.00T | $20.07T | $21.17T | +0.2% |
| Shares issued | 45.25B | 46.81B | 46.81B | 46.81B | 46.88B | -3.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$253.79B | -$174.80B | -$257.73B | -$149.01B | -$158.68B | -45.2% |
| Investing cash flow | -$161.00B | -$146.55B | -$539.88B | $117.04B | -$118.66B | -9.9% |
| Share buybacks | $0 | -$43.99B | -$33.90B | -$332.80B | -$366.74B | +100.0% |
| Dividends paid | — | — | $502.76K | — | — | — |
| Financing cash flow | -$442.63B | -$60.16B | -$265.30B | -$1.78T | -$423.13B | -635.8% |
| Free cash flow | $736.67B | $89.42B | $836.45B | $807.74B | $185.89B | +723.9% |
| End cash position | $4.83T | $4.39T | $4.33T | $3.80T | $4.54T | +10.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $10.18T | +14.3% |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $38.66T | +9.4% |
| Next year | — | — | $41.80T | +8.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders64.87%
Held by institutions10.59%
Institutions holding121
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.05
-0.00% from price
SMA 20
0.05
0.00% from price
SMA 50
0.05
+8.52% from price
SMA 100
0.05
+14.60% from price
SMA 200
0.06
-5.00% from price
EMA 12
0.05
+0.09% from price
EMA 26
0.05
+1.82% from price
EMA 50
0.05
+5.54% from price
RSI (14)
97.9
Overbought
MACD (12,26,9)
0.00
Hist -0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.05
20, 2σ
Bollinger lower
0.05
20, 2σ
50 / 200 cross
Death
0.05 vs 0.06
Trend bias
Below 200
-5.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
0.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-51.2%
Peak to trough
Max drawdown 5Y
-76.3%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
-0.05
5Y monthly, from filing
Dividends & splits
Forward rate$0.00 / yr
Forward yield2.13%
5-year avg yield2.21%
Payout ratio25.19%
Ex-dividend dateJun 4, 2026
Next pay dateJul 7, 2017
Last split—
Split date—
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.